https://www.pbs.org/newshour/show/as-a-virus-ravag
Post# of 72440
I think Leo knows the market better than many give him credit. I wonder if the antibiotic properties of Brilacidin will help propel it to the front of the line. Either way, I expect we hear more within a week or two about its forward motion within the pack.